T cells generated following peptide vaccination may exhibit low avidity for tumor cells, possibly as a result of preferential expansion of lower affinity effectors by APC presenting supraphysiologic concentrations of peptide MHC [2,33]. Here, HLA-C is linked to neoplasm.